Michael J. Ambrogi, Chief Operating Officer at NovoCure Ltd (NVCR), sold 5,346 shares at $72.22 ($386K) on 2020-02-28, disclosed to the SEC on 2020-03-02.
Open-market sale of $386k NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.22 | 2,673 | $193K | 50.0% |
| 2 | $72.22 | 2,673 | $193K | 50.0% |
| Total | $72.22 avg | 5,346 | $386K | 100% |
| Filing → |
| NVCR | SELL | 2020-03-10 | $316K | — | Filing → |
| NVCR | SELL | 2020-02-26 | $1.9M | — | Filing → |
| NVCR | SELL | 2019-11-06 | $6.4M | — | Filing → |